Canopy Growth Corporation (CGC)
Automate Your Wheel Strategy on CGC
With Tiblio's Option Bot, you can configure your own wheel strategy including CGC - and automate your put writes, covered calls, and full wheel strategy. Just connect one of the supported brokerages: tastytrade, Schwab, TradeStation or Tradier and go.
Start Your Free Trial NowKey Metrics & Ratings
- symbol CGC
- Rev/Share 0.8057
- Book/Share 2.1942
- PB 0.7181
- Debt/Equity 0.3365
- CurrentRatio 5.3377
- ROIC -0.0824
- MktCap 810681924.1784
- FreeCF/Share -0.2509
- PFCF -9.351
- PE -1.667
- Debt/Assets 0.2306
- DivYield 0
- ROE -0.5288
- Rating B-
- Score 2
- Recommendation Sell
- P/E Score 1
- DCF Score 5
- P/B Score 4
- D/E Score 2
Recent Analyst Ratings
| Type | Ticker | Analyst Firm | Previous Rating | Current Rating | Previous Price Target | Current Price Target | Date |
|---|---|---|---|---|---|---|---|
| Upgrade | CGC | The Benchmark Company | Sell | Hold | -- | -- | Nov. 10, 2025 |
News
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Published: February 24, 2026 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Canadian Marijuana Stock Picks For Investors 2026
Published: February 20, 2026 by: MarijuanaStocks
Sentiment: Positive
There have been many changes and phases to legal cannabis around the globe. With the USA being the biggest market and Canada becoming the first to outright legalize the plant. This has been a slow uphill climb as laws and regulatory matters have made things anything but easy. However, this has not deterred potential investors from seeing an opportunity. Marijuana stocks have offered the average investor or person a chance to enter the space.
Read More
Should Canopy Growth Stock Be in Your Portfolio Post Q3 Earnings?
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
CGC beats Q3 estimates as Canadian cannabis sales rise, but margin pressure and global volatility cloud its path to sustained profitability.
Read More
Canopy Growth Corporation (CGC) Is a Trending Stock: Facts to Know Before Betting on It
Published: February 11, 2026 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
Canopy Growth Corporation (WEED:CA) Q3 2026 Earnings Call Transcript
Published: February 06, 2026 by: Seeking Alpha
Sentiment: Neutral
Canopy Growth Corporation (WEED:CA) Q3 2026 Earnings Call Transcript
Read More
Canopy Growth Corporation (CGC) Reports Q3 Loss, Tops Revenue Estimates
Published: February 06, 2026 by: Zacks Investment Research
Sentiment: Negative
Canopy Growth Corporation (CGC) came out with a quarterly loss of $0.1 per share versus the Zacks Consensus Estimate of a loss of $0.03. This compares to a loss of $0.76 per share a year ago.
Read More
Can Cannabis Strength in Canada Drive Canopy's Q3 Earnings?
Published: February 02, 2026 by: Zacks Investment Research
Sentiment: Positive
CGC heads into Q3 with Canada cannabis momentum, new product launches and a $50.6M revenue view ahead of Feb. 6 results.
Read More
TLRY vs. CGC: Which Cannabis Stock is the Better Investment Now?
Published: January 30, 2026 by: Zacks Investment Research
Sentiment: Positive
Tilray Brands' international revenue surge, beverage scale and strong cash position give it an edge over Canopy Growth as cannabis regulation and demand continue to evolve.
Read More
February 2026 Watchlist: Leading Canadian Cannabis Stocks
Published: January 27, 2026 by: MarijuanaStocks
Sentiment: Positive
The Canadian cannabis sector continues evolving as companies adapt to shifting consumer demand and global regulations. While volatility remains common, long-term opportunities still attract patient investors. Moreover, potential U.S. federal reform continues to influence sentiment across Canadian operators. Many Canadian companies maintain indirect exposure to the U.S. cannabis market through branding, distribution, and strategic investments. As a result, these stocks often move in step with U.S. multi-state operators during major policy headlines.
Read More
Investors Heavily Search Canopy Growth Corporation (CGC): Here is What You Need to Know
Published: January 22, 2026 by: Zacks Investment Research
Sentiment: Positive
Canopy Growth (CGC) has been one of the stocks most watched by Zacks.com users lately. So, it is worth exploring what lies ahead for the stock.
Read More
3 Canadian Marijuana Stocks For Investors In 2026
Published: January 16, 2026 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is set to reach new horizons in 2026. More companies are coming together to take the industry to a level yet to be seen. With bigger and better partnerships taking effect this year, consumer demand should go beyond mere satisfaction. Along with the political climate around cannabis in the US, marijuana stocks could see a jump from all of the above. 2026 brings in a large amount of positive speculation with all that is going on.
Read More
Canopy Growth Corporation (CGC) is Attracting Investor Attention: Here is What You Should Know
Published: January 08, 2026 by: Zacks Investment Research
Sentiment: Positive
Zacks.com users have recently been watching Canopy Growth (CGC) quite a bit. Thus, it is worth knowing the facts that could determine the stock's prospects.
Read More
The 2026 Cannabis Wildcard: How Tax Reform Could Reset Stock Valuations
Published: December 30, 2025 by: MarketBeat
Sentiment: Neutral
On Dec. 18, 2025, President Trump signed a pivotal Executive Order directing the Attorney General to expedite the rescheduling of cannabis. By all traditional metrics, this political victory should have sparked a sustained rally.
Read More
3 Marijuana Stocks To Watch In 2026
Published: December 26, 2025 by: MarijuanaStocks
Sentiment: Positive
The cannabis industry is entering another critical growth phase, positioning 2026 as a potentially pivotal year. Particularly for long-term investors looking to make a profit with marijuana stocks. After years of regulatory uncertainty, capital constraints, and volatile price action, relief is being shown. The legal cannabis market is showing clear signs of structural improvement driven by policy reform, consolidation, and expanding global demand.
Read More
3 Top Marijuana Stocks After Cannabis Gets Rescheduled
Published: December 22, 2025 by: MarijuanaStocks
Sentiment: Positive
Donald Trump's recent executive order moving cannabis off Schedule I marks a pivotal moment for the U.S. cannabis sector. While the order does not legalize marijuana at the federal level, rescheduling fundamentally changes how the plant is viewed under federal law. With meaningful implications for operators, investors, and public markets. For the cannabis industry, the most immediate impact is financial. A shift to Schedule III would effectively eradicate IRS Section 280E. This is a law that currently prevents cannabis businesses from deducting standard operating expenses.
Read More
3 Best Cannabis Stocks: Will They Fly High Again Post Trump Schedule III?
Published: December 19, 2025 by: Seeking Alpha
Sentiment: Neutral
Cannabis stocks sold off this week following President Trump's Executive Order directing marijuana's reclassification to Schedule III for increased medical and cannabidiol research. The sharp selloff highlights how fragile sentiment in cannabis stock remains, even amid policy progress. Further volatility is possible if regulatory implementation drags on or if broader market risk appetite weakens.
Read More
Trump signs executive order to reschedule cannabis. Here's what's next
Published: December 19, 2025 by: CNBC Television
Sentiment: Positive
Trump's executive order shifts cannabis from Schedule I to Schedule III, and launches a Medicare pilot program for CBD products. Brandon Gomez unpacks what's next, the hurdles ahead and what shifted the President's stance on the drug.
Read More
Trump just legalized marijuana nationwide — here's why potheads are rejoicing
Published: December 19, 2025 by: New York Post
Sentiment: Positive
As On The Money has been reporting since April, our famously drug-and-drink-averse president has been inching ever closer to making marijuana significantly less criminal in the eyes of the federal government.
Read More
Trump Orders Marijuana Reclassification: What It Means for the Sector
Published: December 19, 2025 by: Zacks Investment Research
Sentiment: Positive
Trump's executive order to move marijuana to Schedule III could reshape cannabis regulation and taxes, lifting sentiment around cannabis stocks.
Read More
Trump sparks market shock with MAJOR marijuana move
Published: December 19, 2025 by: Fox Business
Sentiment: Negative
Rep. Greg Steube, R-Fla., joins ‘Mornings with Maria' to discuss cutting healthcare costs, the fight over Obamacare subsidies and shutdown risks, President Donald Trump's marijuana order and the GOP's push to sell unused federal buildings.
Read More
Trump signs executive order to reschedule marijuana, expand access to CBD products
Published: December 18, 2025 by: Proactive Investors
Sentiment: Positive
President Donald Trump on Thursday signed an executive order directing the federal government to move marijuana from Schedule I to Schedule III, potentially easing regulatory and financial constraints for cannabis companies while keeping recreational use illegal under federal law. The order instructs the attorney general to expedite the ongoing process of rescheduling marijuana, which is currently classified alongside heroin and LSD as a Schedule I drug — considered to have a high potential for abuse and no accepted medical use.
Read More
President Trump signs executive order to reclassify marijuana, easing federal restrictions
Published: December 18, 2025 by: CNBC Television
Sentiment: Positive
President Trump signs an executive order to reclassify marijuana to a Schedule III classification, easing federal restrictions.
Read More
Trump Signs Order Easing Federal Restrictions on Marijuana
Published: December 18, 2025 by: Bloomberg Markets and Finance
Sentiment: Positive
President Donald Trump signs an executive order directing his administration to move cannabis into a less restrictive federal category. Sign up for the Washington Edition newsletter to find out how the worlds of money and politics intersect in the US capital: https://bloom.bg/3KkEimO -------- More on Bloomberg Television and Markets Like this video?
Read More
Trump signs executive order easing federal restrictions on marijuana
Published: December 18, 2025 by: Business Insider
Sentiment: Positive
Trump signed an executive order that will reclassify marijuana as a less harmful drug. The order is aimed at making it easier to research the drug.
Read More
Trump signs executive order reclassifying pot, opening door to broader access
Published: December 18, 2025 by: CNBC
Sentiment: Positive
President Donald Trump signed an executive order Thursday reclassifying marijuana as a Schedule III substance with looser restrictions.
Read More
Trump moves to ease cannabis restrictions - what does it mean for consumers?
Published: December 18, 2025 by: Reuters
Sentiment: Positive
U.S. President Donald Trump said he will direct the U.S. Department of Justice to reclassify cannabis as a less dangerous drug. Here's a look at what that would mean for people shopping at dispensaries across the country.
Read More
Cannabis stocks rise ahead of potential Trump order to ease marijuana restrictions
Published: December 18, 2025 by: Reuters
Sentiment: Positive
Shares of cannabis firms rose in premarket trading on Thursday, driven by expectations that U.S. President Donald Trump will sign an executive order easing federal regulations on marijuana.
Read More
Pot stocks pop on Schedule 3 hopes: Tilray Brands, Trulieve Cannabis, Cresco Labs: How high will they go?
Published: December 17, 2025 by: Fast Company
Sentiment: Positive
Shares of publicly traded companies operating in the cannabis space continue to perform strongly as the Trump administration considers reclassifying marijuana.
Read More
Canopy Growth to acquire MTL Cannabis, expanding Québec presence
Published: December 16, 2025 by: Proactive Investors
Sentiment: Positive
Canopy Growth Corporation (TSX:WEED, NYSE:CGC) announced that it has agreed to acquire MTL Cannabis (CSE:MTLC) in a transaction valued at approximately C$125 million on a fully diluted equity basis and about C$179 million on an enterprise value basis. Under the terms of a definitive arrangement agreement, Canopy Growth will acquire all issued and outstanding shares of MTL Cannabis and settle the target's outstanding debt and debt-like instruments.
Read More
Best Canadian Cannabis Stocks to Watch This Week for Traders and Investors
Published: December 16, 2025 by: MarijuanaStocks
Sentiment: Positive
Canadian cannabis stocks remain in focus this week as sector sentiment continues improving. Several Canadian operators maintain meaningful exposure to the U.S. market through brands and partnerships. Meanwhile, the U.S. cannabis industry continues expanding despite regulatory delays. Total U.S. cannabis sales now exceed $32 billion annually. Importantly, analysts project the market could surpass $50 billion by 2030. That growth outlook keeps Canadian operators relevant for global investors. Recently, renewed federal reform discussions returned to headlines. Cannabis rescheduling remains under active government review. Additionally, lawmakers continue debating banking access and tax reform measures. While timing remains uncertain, momentum has improved compared …
Read More
About Canopy Growth Corporation (CGC)
- IPO Date 2014-04-07
- Website https://www.canopygrowth.com
- Industry Drug Manufacturers - Specialty & Generic
- CEO Luc Mongeau
- Employees 1029